Wells Fargo & Company Co Diagnostics, Inc. Transaction History

Wells Fargo & Company

$468 Billion
Q2 2025

A detailed history of Wells Fargo & Company transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 275 shares of CODX stock, worth $101. This represents 0.0% of its overall portfolio holdings.

Number of Shares

275

Previous 275 -0.0%

Holding current value

$101

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$0.31 - $1.0 $279 - $900	-900 Reduced 76.6%	275 $0
Q3 2024 Nov 13, 2024	BUY	$1.02 - $1.75 $918 - $1,575	900 Added 327.27%	1,175 $1,000
Q2 2024 Aug 13, 2024	SELL	$1.01 - $1.7 $746 - $1,256	-739 Reduced 72.88%	275 $0
Q1 2024 May 10, 2024	SELL	$1.06 - $1.42 $1,585 - $2,124	-1,496 Reduced 59.6%	1,014 $1,000
Q4 2023 Feb 09, 2024	BUY	$1.0 - $1.5 $210 - $315	210 Added 9.13%	2,510 $3,000
Q3 2023 Nov 13, 2023	SELL	$1.03 - $1.85 $3,803 - $6,832	-3,693 Reduced 61.62%	2,300 $2,000
Q2 2023 Aug 15, 2023	SELL	$1.04 - $1.64 $1,867 - $2,945	-1,796 Reduced 23.06%	5,993 $6,000
Q1 2023 May 12, 2023	BUY	$1.39 - $3.24 $247 - $576	178 Added 2.34%	7,789 $11,000
Q4 2022 Feb 13, 2023	SELL	$2.32 - $3.68 $15,864 - $25,163	-6,838 Reduced 47.33%	7,611 $19,000
Q3 2022 Nov 14, 2022	SELL	$2.87 - $7.01 $16,043 - $39,185	-5,590 Reduced 27.9%	14,449 $47,000
Q2 2022 Aug 12, 2022	SELL	$3.76 - $6.29 $41,096 - $68,749	-10,930 Reduced 35.29%	20,039 $112,000
Q1 2022 May 16, 2022	BUY	$5.03 - $9.61 $24,581 - $46,964	4,887 Added 18.74%	30,969 $191,000
Q4 2021 Feb 14, 2022	BUY	$8.12 - $10.37 $109,668 - $140,057	13,506 Added 107.4%	26,082 $232,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $1,092 - $1,661	146 Added 1.17%	12,576 $123,000
Q2 2021 Aug 16, 2021	SELL	$7.16 - $9.56 $1.82 Million - $2.43 Million	-253,804 Reduced 95.33%	12,430 $102,000
Q1 2021 May 13, 2021	BUY	$8.52 - $19.21 $1.71 Million - $3.86 Million	200,963 Added 307.89%	266,234 $2.54 Million
Q4 2020 Feb 09, 2021	SELL	$9.3 - $15.19 $902,313 - $1.47 Million	-97,023 Reduced 59.78%	65,271 $607,000
Q3 2020 Nov 05, 2020	BUY	$8.24 - $30.8 $717,877 - $2.68 Million	87,121 Added 115.89%	162,294 $2.2 Million
Q2 2020 Aug 13, 2020	BUY	$7.46 - $23.42 $548,272 - $1.72 Million	73,495 Added 4379.92%	75,173 $1.46 Million
Q1 2020 May 14, 2020	BUY	$0.91 - $17.81 $1,526 - $29,885	1,678 New	1,678 $13,000

Others Institutions Holding CODX

# of Institutions

Shares Held

5.08M

Call Options Held

65.5K

Put Options Held

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $12.5M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Co Diagnostics, Inc. Transaction History